English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17939/22958 (78%)
Visitors : 7387051      Online Users : 124
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/15625


    Title: Association between interleukin-18 polymorphisms and hepatocellular carcinoma occurrence and clinical progression
    Authors: Lau, H.-K.;Hsieh, M.-J.;Yang, S.-F.;Wang, H.-L.;Kuo, W.-H.;Lee, H.-L.;Yeh, C.-B.
    Contributors: 醫學研究所
    Keywords: Hepatitis B virus;Hepatocellular carcinoma;Interleukin-18
    Date: 2016-07-05
    Issue Date: 2016-08-04T04:34:12Z (UTC)
    Publisher: Ivyspring International Publisher
    ISSN: 14491907
    Abstract: We investigated the association between interleukin-18 (IL-18) polymorphisms and the susceptibility and clinicopathological state of hepatocellular carcinoma (HCC). In total, 901 participants, including 559 healthy controls and 342 patients with HCC, were recruited. The allelic discrimination of −607A/C (rs1946518) and −137G/C (rs187238) polymorphisms of IL-18 was assessed through real-time polymerase chain reaction by performing the TaqMan assay. The IL-18 −137G/C polymorphism but not the −607A/C polymorphism showed a significant association with the risk of HCC. Participants carrying the IL-18 −137 polymorphism with heterozygous G/C and homozygous CC genotypes showed a 1.987-fold increase (95% CI = 1.301–3.032; p = 0.001) in the risk of HCC compared with those homozygous for wild-type G/G. The 342 patients with HCC carrying the IL-18 −137G/C polymorphism were positive for hepatitis B virus (HBV) infection with an adjusted odds ratio of 1.668. Moreover, the 142 HBV positive patients with HCC and the IL-18 −137 polymorphism were positive for at least one C genotype and showed significant vascular invasion (p = 0.018). Furthermore, the level of α-fetoprotein was high in the patients carrying the IL-18 −137 polymorphism with GC+CC alleles (p = 0.011). In conclusion, the IL-18 −137G/C polymorphism with a GC+CC genotype could be a factor that increases the risk of HCC. Furthermore, the correlation between the IL-18 −137G/C polymorphism and HCC-related HBV infection is a risk factor for vascular invasion and has a synergistic effect that can further enhance HCC prognosis. © 2016, Ivyspring International Publisher. All rights reserved.
    URI: https://ir.csmu.edu.tw:8080/ir/handle/310902500/15625
    http://dx.doi.org/10.7150/ijms.15853
    Relation: International Journal of Medical Sciences Volume 13, Issue 7, 5 July 2016, Pages 556-561
    Appears in Collections:[醫學研究所] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML430View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback